nortriptyline hydrochloride- nortriptyline hydrochloride solution Spojené státy - angličtina - NLM (National Library of Medicine)

nortriptyline hydrochloride- nortriptyline hydrochloride solution

ranbaxy laboratories limited - nortriptyline hydrochloride (unii: 00fn6ih15d) (nortriptyline - unii:bl03sy4lxb) - solution - 10 mg in 5 ml - nortriptyline hydrochloride is indicated for the relief of symptoms of depression. endogenous depressions are more likely to be alleviated than are other depressive states. the concurrent use of nortriptyline hydrochloride or other tricyclic antidepressants with a monoamine oxidase (mao) inhibitor is contraindicated. hyperpyretic crises, severe convulsions, and fatalities have occurred when similar tricyclic antidepressants were used in such combinations. it is advisable to discontinue the mao inhibitor at least 2 weeks before treatment with nortriptyline hydrochloride is to be started. patients hypersensitive to nortriptyline hydrochloride should not be given the drug. cross-sensitivity between nortriptyline hydrochloride and other dibenzazepines is a possibility. nortriptyline hydrochloride is contraindicated during the acute recovery period after myocardial infarction.

HYDROCHLOROTHIAZIDE capsule Spojené státy - angličtina - NLM (National Library of Medicine)

hydrochlorothiazide capsule

ipca laboratories limited - hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - capsule - 12.5 mg - hydrochlorothiazide capsules are indicated in the management of hypertension either as the sole therapeutic agent, or in combination with other antihypertensives. unlike potassium sparing combination diuretic products, hydrochlorothiazide capsules may be used in those patients in whom the development of hyperkalemia cannot be risked, including patients taking ace inhibitors. usage in pregnancy: the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxemia. edema during pregnancy may arise from pathological causes or from the physiologic and mechanical consequences of pregnancy. diuretics are indicated in pregnancy when edema is due to pathologic causes, just as they are in the absence of pregnancy. dependent edema in pregnancy resulting from restriction of venous return by the expanded ut

Fucibet 20 mg/g + 1 mg/g cream Irsko - angličtina - HPRA (Health Products Regulatory Authority)

fucibet 20 mg/g + 1 mg/g cream

leo laboratories limited - betamethasone; fusidic acid - cream - 20 + 1 milligram(s)/gram - corticosteroids, potent, combinations with antibiotics; betamethasone and antibiotics

Fucibet Lipid 20mg/g + 1mg/g cream Irsko - angličtina - HPRA (Health Products Regulatory Authority)

fucibet lipid 20mg/g + 1mg/g cream

leo laboratories limited - fusidic acid; betamethasone - cream - 20 + 1 milligram(s)/gram - corticosteroids, potent, combinations with antibiotics; betamethasone and antibiotics

Fucidin H 20mg/g + 10mg/g Cream Irsko - angličtina - HPRA (Health Products Regulatory Authority)

fucidin h 20mg/g + 10mg/g cream

leo laboratories limited - fusidic acid anhydrous; hydrocortisone acetate - cream - 20 + 10 milligram(s)/gram - corticosteroids, weak, combinations with antibiotics; hydrocortisone and antibiotics

LOXICOM- meloxicam injection, solution Spojené státy - angličtina - NLM (National Library of Medicine)

loxicom- meloxicam injection, solution

norbrook laboratories limited - meloxicam (unii: vg2qf83cgl) (meloxicam - unii:vg2qf83cgl) - meloxicam 5 mg in 1 ml - cats: for the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration when administered prior to surgery. cats with known hypersensitivity to meloxicam should not receive loxicom 5 mg/ml solution for injection. additional doses of meloxicam or other nsaids in cats are contraindicated, as no safe dosage for repeated nsaid administration has been established (see animal safety). do not use meloxicam in cats with pre-existing renal dysfunction. dogs: loxicom® (meloxicam) 5 mg/ml solution for injection is indicated in dogs for the control of pain and inflammation associated with osteoarthritis. dogs with known hypersensitivity to meloxicam should not receive loxicom 5 mg/ml solution for injection.

FLUOXETINE HYDROCHLORIDE capsule, delayed release pellets Spojené státy - angličtina - NLM (National Library of Medicine)

fluoxetine hydrochloride capsule, delayed release pellets

dr.reddy's laboratories limited - fluoxetine hydrochloride (unii: i9w7n6b1kj) (fluoxetine - unii:01k63sup8d) - fluoxetine 90 mg - fluoxetine delayed-release capsules are indicated for the treatment of: • acute and maintenance treatment of major depressive disorder [see clinical studies (14.1)] . the use of maois intended to treat psychiatric disorders with fluoxetine or within 5 weeks of stopping treatment with fluoxetine is contraindicated because of an increased risk of serotonin syndrome. the use of fluoxetine within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated [see dosage and administration (2.9) and warnings and precautions (5.2) ]. starting fluoxetine in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome [see dosage and administration (2.10) and warnings and precautions (5.2) ]. the use of fluoxetine is contraindicated with the following: - pimozide [see warnings and precautions (5.11) and drug interactions (7.7, 7.8) ]. - thioridazine [see warnings and precautions (

FLUOXETINE tablet, film coated Spojené státy - angličtina - NLM (National Library of Medicine)

fluoxetine tablet, film coated

dr.reddy's laboratories limited - fluoxetine hydrochloride (unii: i9w7n6b1kj) (fluoxetine - unii:01k63sup8d) - fluoxetine 10 mg - fluoxetine tablets are indicated for the acute and maintenance treatment of major depressive disorder in adult patients and in pediatric patients aged 8 to18 years [see clinical studies (14.1) ].   the usefulness of the drug in adult and pediatric patients receiving fluoxetine for extended periods should periodically be re-evaluated [see dosage and administration (2.1) ].   fluoxetine tablets are indicated for the acute and maintenance treatment of obsessions and compulsions in adult patients and in pediatric patients aged 7 to 17 years with obsessive compulsive disorder (ocd) [see clinical studies (14.2) ].   the effectiveness of fluoxetine tablets in long-term use, i.e., for more than 13 weeks, has not been systematically evaluated in placebo-controlled trials. therefore, the physician who elects to use fluoxetine tablets for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient [see dosage and administration (2.2) ]. fluoxetine tablets are indicate

CITALOPRAM HYDROBROMIDE tablet, film coated Spojené státy - angličtina - NLM (National Library of Medicine)

citalopram hydrobromide tablet, film coated

dr. reddy's laboratories limited - citalopram hydrobromide (unii: i1e9d14f36) (citalopram - unii:0dhu5b8d6v) - citalopram 10 mg - citalopram tablets are indicated for the treatment of major depressive disorder (mdd) in adults [see clinical studies ( 14)] . citalopram tablets are contraindicated in patients: - taking, or within 14 days of stopping, maois (including maois such as linezolid or intravenous methylene blue) because of an increased risk of serotonin syndrome [see warnings and precautions ( 5.3), drug interactions ( 7)]. - taking pimozide because of risk of qt prolongation [see drug interactions ( 7)] . - with known hypersensitivity to citalopram or any of the inactive ingredients in citalopram tablets. reactions have included angioedema and anaphylaxis [see adverse reactions ( 6.2)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antidepressants during pregnancy. healhcare providers are encouraged to register patients by calling the national pregnancy registry for antidepressants at 1-844-405-6185 or visiting online at https://womensmentalhealth.org/resea

LOXICOM- meloxicam suspension Spojené státy - angličtina - NLM (National Library of Medicine)

loxicom- meloxicam suspension

norbrook laboratories limited - meloxicam (unii: vg2qf83cgl) (meloxicam - unii:vg2qf83cgl) - meloxicam 1.5 mg in 1 ml - loxicom oral suspension is indicated for the control of pain and inflammation associated with osteoarthritis in dogs. dogs with known hypersensitivity to meloxicam should not receive loxicom oral suspension. do not use loxicom oral suspension in cats. acute renal failure and death have been associated with the use of meloxicam in cats.